Assignee
MESSAGE PHARMACEUTICALS
US·7 granted patents·155 citations·filing 1997–2002
Top patents by PatentIndex Score
7 records- 0190US6630589B1Identification of compounds for the treatment or prevention of proliferative diseasesMESSAGE PHARMACEUTICALS·Filed 2002·Granted Oct 7, 2003·32 cites·34 claims
- 0289US6936432B2Bacterial RNase P proteins and their use in identifying antibacterial compoundsMESSAGE PHARMACEUTICALS·Filed 2001·Granted Aug 30, 2005·37 cites·15 claims
- 0383US6872850B2Small molecule inhibitors of secretion of proteins encoded by ARE-mRNAsMESSAGE PHARMACEUTICALS·Filed 2002·Granted Mar 29, 2005·15 cites·8 claims
- 0483US6448007B1Functional genomic screen for post-transcriptional 5′ and 3′ regulatory elementsMESSAGE PHARMACEUTICALS·Filed 2000·Granted Sep 10, 2002·17 cites·33 claims
- 0575US7001924B2Inhibitors of RNase P proteins as antibacterial compoundsMESSAGE PHARMACEUTICALS·Filed 2002·Granted Feb 21, 2006·11 cites·27 claims
- 0671US6004749AMethod for identifying compounds affecting RNA/RNA binding protein interactionsMESSAGE PHARMACEUTICALS·Filed 1997·Granted Dec 21, 1999·42 cites·22 claims
- 0759US7037660B2Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acidsMESSAGE PHARMACEUTICALS·Filed 2002·Granted May 2, 2006·1 cites·41 claims
Join the waitlist — get patent alerts
Get an alert when MESSAGE PHARMACEUTICALS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →